PIK3CD
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
Also known as: p110D, PK3CD_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00329
- Gene
- PIK3CD
- Ensembl
- ENSG00000171608
- Chromosome
- 1
- Canonical length
- 1044 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins
- Subcellular location
- Vesicles,Microtubules,Cytokinetic bridge,Primary cilium,Primary cilium tip,Cytosol
OverviewNCBI Gene
Phosphoinositide 3-kinases (PI3Ks) phosphorylate inositol lipids and are involved in the immune response. The protein encoded by this gene is a class I PI3K found primarily in leukocytes. Like other class I PI3Ks (p110-alpha p110-beta, and p110-gamma), the encoded protein binds p85 adapter proteins and GTP-bound RAS. However, unlike the other class I PI3Ks, this protein phosphorylates itself, not p85 protein.[provided by RefSeq, Jul 2010]
Canonical amino-acid sequenceUniProt
1044 residues, UniProt reviewed canonical sequence.
>O00329|PIK3CD
1 MPPGVDCPME FWTKEENQSV VVDFLLPTGV YLNFPVSRNA NLSTIKQLLW HRAQYEPLFH
61 MLSGPEAYVF TCINQTAEQQ ELEDEQRRLC DVQPFLPVLR LVAREGDRVK KLINSQISLL
121 IGKGLHEFDS LCDPEVNDFR AKMCQFCEEA AARRQQLGWE AWLQYSFPLQ LEPSAQTWGP
181 GTLRLPNRAL LVNVKFEGSE ESFTFQVSTK DVPLALMACA LRKKATVFRQ PLVEQPEDYT
241 LQVNGRHEYL YGSYPLCQFQ YICSCLHSGL TPHLTMVHSS SILAMRDEQS NPAPQVQKPR
301 AKPPPIPAKK PSSVSLWSLE QPFRIELIQG SKVNADERMK LVVQAGLFHG NEMLCKTVSS
361 SEVSVCSEPV WKQRLEFDIN ICDLPRMARL CFALYAVIEK AKKARSTKKK SKKADCPIAW
421 ANLMLFDYKD QLKTGERCLY MWPSVPDEKG ELLNPTGTVR SNPNTDSAAA LLICLPEVAP
481 HPVYYPALEK ILELGRHSEC VHVTEEEQLQ LREILERRGS GELYEHEKDL VWKLRHEVQE
541 HFPEALARLL LVTKWNKHED VAQMLYLLCS WPELPVLSAL ELLDFSFPDC HVGSFAIKSL
601 RKLTDDELFQ YLLQLVQVLK YESYLDCELT KFLLDRALAN RKIGHFLFWH LRSEMHVPSV
661 ALRFGLILEA YCRGSTHHMK VLMKQGEALS KLKALNDFVK LSSQKTPKPQ TKELMHLCMR
721 QEAYLEALSH LQSPLDPSTL LAEVCVEQCT FMDSKMKPLW IMYSNEEAGS GGSVGIIFKN
781 GDDLRQDMLT LQMIQLMDVL WKQEGLDLRM TPYGCLPTGD RTGLIEVVLR SDTIANIQLN
841 KSNMAATAAF NKDALLNWLK SKNPGEALDR AIEEFTLSCA GYCVATYVLG IGDRHSDNIM
901 IRESGQLFHI DFGHFLGNFK TKFGINRERV PFILTYDFVH VIQQGKTNNS EKFERFRGYC
961 ERAYTILRRH GLLFLHLFAL MRAAGLPELS CSKDIQYLKD SLALGKTEEE ALKHFRVKFN
1021 EALRESWKTK VNWLAHNVSK DNRQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PIK3CD can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 45 nTPM
Expression across tissuesHPA
Tissue
- spleen: 45 nTPM
- bone marrow: 44 nTPM
- lymph node: 42 nTPM
- appendix: 29 nTPM
- tonsil: 28 nTPM
- thymus: 24 nTPM
Single-cell type
- neutrophils: 828 nCPM
- neutrophil progenitors: 341 nCPM
- pdcs: 245 nCPM
- monocyte progenitors: 191 nCPM
- kupffer cells: 163 nCPM
- nk-cells: 159 nCPM
Immune cell
- neutrophil: 65 nTPM
- eosinophil: 40 nTPM
- total PBMC: 40 nTPM
- non-classical monocyte: 30 nTPM
- NK-cell: 28 nTPM
- naive CD8 T-cell: 26 nTPM
Brain region
- thalamus: 14 nTPM
- white matter: 12 nTPM
- pons: 11 nTPM
- cerebral cortex: 9.6 nTPM
- medulla oblongata: 9.6 nTPM
- amygdala: 9.2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PIK3CD.
Disease | AllUniProt
Conditions PIK3CD is implicated in, by any mechanism.
- Immunodeficiency 14A with lymphoproliferation, autosomal dominant (IMD14A) MIM:615513
- Immunodeficiency 14B, autosomal recessive (IMD14B) MIM:619281
- Roifman-Chitayat syndrome (ROCHIS) MIM:613328
Disease | GeneticClinVar
34 pathogenic / likely-pathogenic of 1,044 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Immunodeficiency 14
- Immunodeficiency 14b, autosomal recessive
- Combined immunodeficiency with faciooculoskeletal anomalies
- Inherited Immunodeficiency Diseases
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.2
- gnomAD pLI
- 1
- gnomAD missense Z
- 4.27
- DepMap mean gene effect
- -0.17
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- B cell activation
- B cell chemotaxis
- B cell differentiation
- B cell receptor signaling pathway
- cell migration
- immune response
- inflammatory response
- innate immune response
- mast cell chemotaxis
- mast cell degranulation
- mast cell differentiation
- natural killer cell activation
- natural killer cell chemotaxis
- natural killer cell differentiation
- neutrophil chemotaxis
- neutrophil extravasation
- phosphatidylinositol 3-kinase/protein kinase B signal transduction
- phosphatidylinositol-3-phosphate biosynthetic process
- phosphatidylinositol-mediated signaling
- positive regulation of angiogenesis
- positive regulation of cell migration
- positive regulation of cytokine production
- positive regulation of endothelial cell migration
- positive regulation of endothelial cell proliferation
- positive regulation of epithelial tube formation
- positive regulation of gene expression
- positive regulation of neutrophil apoptotic process
- protein phosphorylation
- respiratory burst involved in defense response
- signal transduction
- T cell activation
- T cell chemotaxis
- T cell costimulation
- T cell differentiation
- T cell receptor signaling pathway
- vascular endothelial growth factor signaling pathway
Molecular functions
- 1-phosphatidylinositol-3-kinase activity
- 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity
- 1-phosphatidylinositol-4-phosphate 3-kinase activity
- ATP binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Phosphatidylinositol 3-kinase Ras-binding (PI3K RBD) domain
- Phosphatidylinositol 3-/4-kinase, catalytic domain
- Phosphoinositide 3-kinase, accessory (PIK) domain
- C2 phosphatidylinositol 3-kinase-type domain
- Phosphatidylinositol 3-kinase, adaptor-binding domain
- Protein kinase-like domain superfamily
- Phosphatidylinositol 3-/4-kinase
- Armadillo-type fold
- Phosphatidylinositol 3-/4-kinase, conserved site
- Ubiquitin-like domain superfamily
- C2 domain superfamily
- Phosphatidylinositol 3-/4-kinase, catalytic domain superfamily
- Phosphoinositide 3-kinase, accessory (PIK) domain superfamily
- Phosphatidylinositol 3- and 4-kinase
- Phosphoinositide 3-kinase family, accessory domain (PIK domain)
- Phosphoinositide 3-kinase C2
- PI3-kinase family, ras-binding domain
- PI3-kinase family, p85-binding domain
- Phosphatidylinositol 3-kinase delta, catalytic domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PIK3CD in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PIK3CD as an antibody target. Whether an autoantibody or antibody against PIK3CD could matter depends on whether native PIK3CD is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PIK3CD is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PIK3CD as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...